Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-13 Greenstreet Yvonne Chief Executive Officer Grant or award +3,859 82,739
2025-02-13 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +3,109 33,753
2025-02-13 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award 10b5-1 +2,103 14,984
2025-02-13 Garg Pushkal CMO & EVP Dev & Med Affairs Grant or award 10b5-1 +3,109 15,098
2025-01-27 Garg Pushkal CMO & EVP Dev & Med Affairs Option exercise 10b5-1 +23,876 $88.95 $2.1M 39,581
2025-01-27 Garg Pushkal CMO & EVP Dev & Med Affairs Option exercise 10b5-1 +25,000 $88.95 $2.2M 64,581
2025-01-27 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −52,592 $285.00 $15.0M 11,989
2025-01-27 Garg Pushkal CMO & EVP Dev & Med Affairs Option exercise · Performance Stock Option 2015 (right to buy) 10b5-1 −25,000 0
2025-01-27 Garg Pushkal CMO & EVP Dev & Med Affairs Option exercise · Stock Option (right to buy) 10b5-1 −23,876 0
2025-01-23 SHARP PHILLIP A Director Option exercise 10b5-1 +11,250 $131.21 $1.5M 11,250
2025-01-23 SHARP PHILLIP A Director Sale 10b5-1 −11,250 $275.00 $3.1M 0
2025-01-23 SHARP PHILLIP A Director Option exercise · Stock Option (right to buy) 10b5-1 −11,250 0
2024-12-12 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −121 $247.48 $30K 17,336
2024-12-12 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −186 $248.99 $46K 17,150
2024-12-12 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −426 $250.08 $107K 16,724
2024-12-12 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −778 $251.68 $196K 15,946
2024-12-12 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −100 $252.94 $25K 15,846
2024-12-12 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −140 $254.37 $36K 15,706
2024-12-12 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −1 $255.80 $256 15,705
2024-11-26 Greenstreet Yvonne Chief Executive Officer Sale −93 $247.77 $23K 84,006

Page 39 of 41 · 816 trades